All News

The big event in the Open Source community this week is Microsoft's Open Specification Promise, published on Microsoft's web site on September 12. What Microsoft promises is that no developer or programmer will be harassed or sued for infringement of 35 patents Microsoft holds in the area of web services specifications, if he/she uses those specifications to develop open-source applications.

A blog from Switzerland provides insights on what is hot in the land of the venture capitalist.

A new research lab brings together a chemicals giant and academics to accelerate the development of organic electronics.

Are our politicians really using science to make the best decisions? Or are they just hiding behind science, rather than using their common sense?

Europe came a step closer to ensuring its future competitiveness last week when member states endorsed a programme of sustainable chemistry.

European companies are set to increase their investment in R&D by 5 per cent per annum over the next three years, closing the gap with US counterparts.

European venture capitalists are no longer prepared to take any risk with their investments, undermining the biotech sector. That, anyway, is the opinion of many a frustrated biotech entrepreneur.

Who should profit from cutting-edge academic research: the scientists or the institution that funds them? Both, in a new biotech company launched by one of Sweden’s leading researchers.

A pay-per-vote Web site offers a new way to fund science, one dollar at a time.

A confluence of drought and rapidly growing demand is spurring the development of water technologies.